N
BDSI

Nuveen’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Nuveen’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,343,230
Closed -$4.16M – 3470
2021
Q4 		$4.16M Buy
1,343,230
+23,507
+2% +$79.1K ﹤0.01% 2226
2021
Q3 		$5.27M Sell
1,319,723
-43,532
-3% -$164K ﹤0.01% 2183
2021
Q2 		$4.88M Sell
1,363,255
-105,242
-7% -$371K ﹤0.01% 2264
2021
Q1 		$5.74M Sell
1,468,497
-390,357
-21% -$1.61M ﹤0.01% 2105
2020
Q4 		$7.81M Buy
1,858,854
+68,306
+4% +$263K ﹤0.01% 1855
2020
Q3 		$6.68M Sell
1,790,548
-28,015
-2% -$119K ﹤0.01% 1763
2020
Q2 		$7.93M Buy
1,818,563
+106,658
+6% +$479K ﹤0.01% 1645
2020
Q1 		$6.49M Sell
1,711,905
-67,726
-4% -$333K ﹤0.01% 1562
2019
Q4 		$11.2M Buy
1,779,631
+451,542
+34% +$2.65M ﹤0.01% 1515
2019
Q3 		$5.59M Buy
1,328,089
+820,982
+162% +$3.51M ﹤0.01% 1896
2019
Q2 		$2.36M Buy
+507,107
New +$2.36M ﹤0.01% 2353

Other funds holding BDSI

CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return
FCMT
Founders Capital Management (Texas) Houston, Texas $205M AUM 41.7% 1-Year Est. Return

Nuveen's BDSI Position: Q1 2022 in Review

Nuveen sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 1,343,230 shares — an estimated $4.16M sold.

Nuveen first reported a position in BDSI in Q2 2019 and held it in 11 quarters. The position peaked at $11.2M in Q4 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • Nuveen reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • Nuveen sold 1,343,230 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $4.16M.
  • Nuveen first reported a position in BioDelivery Sciences International, Inc. in Q2 2019 and held it in 11 quarters.
  • Nuveen's BioDelivery Sciences International, Inc. position peaked at $11.2M in Q4 2019.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Nuveen's 13F filing for Q1 2022, filed 16 May 2022.